Cargando…
Identification and Enhancement of HLA-A2.1-Restricted CTL Epitopes in a New Human Cancer Antigen-POTE
Identification of CD8(+) T cell epitopes that can induce T cells to kill tumor cells is a fundamental step for development of a peptide cancer vaccine. POTE protein is a newly identified cancer antigen that was found to be expressed in a wide variety of human cancers, including prostate, colon, lung...
Autores principales: | Huang, Yi-Hsiang, Terabe, Masaki, Pendleton, C. David, Stewart Khursigara, Deborah, Bera, Tapan K., Pastan, Ira, Berzofsky, Jay A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3672105/ https://www.ncbi.nlm.nih.gov/pubmed/23750208 http://dx.doi.org/10.1371/journal.pone.0064365 |
Ejemplares similares
-
Combining anti-CTLA4 with RG7787, an immunotoxin targeting mesothelin, promotes tumor eradication
por: Leshem, Jasmin, et al.
Publicado: (2015) -
HLA-A*0201-restricted CTL epitope of a novel osteosarcoma antigen, papillomavirus binding factor
por: Tsukahara, Tomohide, et al.
Publicado: (2009) -
Identification of Novel HLA-A*0201-Restricted CTL Epitopes in Chinese Vitiligo Patients
por: Cui, Tingting, et al.
Publicado: (2016) -
Identification of HLA-A2 or HLA-A24-restricted CTL epitopes for potential HSP105-targeted immunotherapy in colorectal cancer
por: SAWADA, YU, et al.
Publicado: (2014) -
Identification of Two Novel HLA-A*0201-Restricted CTL Epitopes Derived from MAGE-A4
por: Jia, Zheng-Cai, et al.
Publicado: (2010)